JAZZ vs OWL · P/E 1988, rev $2.28B vs P/E 79, rev $275.1M
Jazz Pharmaceuticals PLC (JAZZ) versus Blue Owl Capital Inc (OWL) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Blue Owl Capital Inc (OWL) is a asset management company listed on NYSE.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported OWL revenue for 2026-06-30 was $275.1M. Net income was $26.9M. Revenue was up 99.3% from 2026-03-31 to 2026-06-30. OWL currently screens at market cap $14.82B and trailing P/E 79.2.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. OWL currently screens at market cap $14.82B and trailing P/E 79.2.
Not investment advice. Open the JAZZ and OWL stock pages for the full models.
Not investment advice.